Share Twitter LinkedIn Facebook Email Nizar Bahlis, MD University of Calgary, Calgary, discusses The Future Of Anti-BCMA CAR-T Cell Therapy In MM. At The 60th ASH Annual Meeting on Dec 1, 2018. http://obroncology.com
53 vs 31 Month Isatuximab-VRD Results: My Interview with SANOFI’s Global Product Head at ASCO 2024 ASCO Annual Meeting 2 Mins Read